Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase II Clinical Study of A Selective Estrogen Receptor Modulator vs.-261995000
Cleveland Clinic Lerner, Cleveland, OH, United States
Search grants from Cleveland Clinic Lerner
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Expanding Coordinated HIV Prevention, Strategic Information and Laboratory Progra
National Heart, Lung, and Blood Institute Proteomics Initiative
Development of Enzyme Immunoassays for Murine Cytokines
AIDS Education and Training Center
Professional Nurse Traineeship Program
Recently added grants:
Teamwork, Targets, Technology, and Tight Control in Newly Diagnosed Pediatric T1D: 4T Study
Mechanistically based therapeutic strategies in murine primary biliary cholangitis
Use of Continuous Glucose Monitoring (CGM) in End-Stage Renal Disease (ESRD) Patients with Type 2 Diabetes
Pilot Study of the Nutrition-Enhanced Wellness for Diabetes Self-Management Program (NEW-DSMP) among Low-Income Adults with Type II Diabetes
Combining experiments of man and nature to target human insulin resistance
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CA095000-004
Application #
6828928
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2003
Total Cost
Indirect Cost
Institution
Name
Cleveland Clinic Lerner
Department
Type
DUNS #
017730458
City
Cleveland
State
OH
Country
United States
Zip Code
44195
Related projects
NIH 2003
N01 CA
Phase II Clinical Study of A Selective Estrogen Receptor Modulator vs.-261995000
/ Cleveland Clinic Lerner
NIH 2002
N01 CA
Phase II Clinical Study of A Selective Estrogen Receptor Modulator vs.-261995000
/ Cleveland Clinic Lerner
Comments
Be the first to comment on this grant